Flagship Harbor Advisors, LLC Clovis Oncology, Inc. Transaction History

Flagship Harbor Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$4.13 - $6.41 $413 - $641	-100 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$5.69 - $9.69 $796 - $1,356	-140 Reduced 58.33%	100 $0
Q4 2019 Feb 14, 2020	BUY	$3.0 - $16.43 $330 - $1,807	110 Added 84.62%	240 $3,000
Q1 2019 Apr 15, 2019	BUY	$17.66 - $30.28 $529 - $908	30 Added 30.0%	130 $3,000
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $4,206 - $6,240	100 New	100 $4,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.